Because the BCL2A113P was found at an allelic frequency of 49.3%, this mutant form of BCL2 was found in virtually all CLL cells at SC2, but in none of the CLL cells at SC1, demonstrating strong selection of this mutant BCL2 in the treated CLL population. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.